The role of barrier function of mucous membranes in allergic diseases and sublingual allergen-specific immunotherapy
https://doi.org/10.20538/1682-0363-2017-2-32-46
Abstract
Currently one of the factors of allergy predisposition is the increase in barrier permeability of the mucous membranes of the respiratory system and the gastrointestinal tract (GIT). It defines the probability of an emergence of an allergic response. To understand the mechanisms of the interaction of the mucous membranes of different systems that explain their common function is undoubtedly necessary for discussion of this problem. The features of microbiome influence and the changes of the microbiome state during the formation of the immune response to the contact with allergens are of particular interest. The structure of the epithelial barrier of the airwaysand GIT, and mechanisms of allergen transport through barrier systems with the subsequent interaction with the cells (?) associated with barrier fabrics have been considered. The possible role of the barrier function of mucous membranes in conducting sublingual allergen-specific immunotherapy (SLIT) is discussed.
About the Authors
Oksana M. Kurbacheva
National Research Center (NRC) Institute of Immunology
Russian Federation
Russian Federation
DM, Professor
24, Kashirskoye Highway, Moscow, 115478
Miramgul E. Amanturlieva
National Research Center (NRC) Institute of Immunology
Russian Federation
Russian Federation
Allergy Resident
24, Kashirskoye Highway, Moscow, 115478
References
1. Tsyvkina A.A., Luss L.V., Tsarev S.V. Mukozal’nyj immunitet pri patologii verhnih dyhatel’nyh putej [Mucosal immunity in the upper airways dysfunction] // Rossijskij allergologicheskij zhurnal – Russian Allergology Journal. 2011; 2: 22–25 (in Russian).
2. Vykhrystsenko L.R. Mehanizmy peroral’noj tolerantnosti k allergenam [Mechanisms of oral tolerance to allergens] // Immunopatologija, allergologija, infektologija – Immunopathology, Аllergology, Infectology. 2015; 4: 16–24. doi: 10.14427/jipai.2015.4.16 (in Russian).
3. Shabashova N.V., Danilova E.U. Mestnyj immunitet i mikrobiota rotovoj polosti (obzor) [Mucosal immunity and oral microbiota (Review)] // Problemy medicinskoj mikologii – Problems in Medical Mycology. 2015; 17 (4): 4–12 (in Russian).
4. Gushchin I.S. Transjepitelial’nyj zapusk allergicheskogo otveta [Transepithelial initiation of allergic response] // Rossijskij allergologicheskij zhurnal – Russian Allergology Journal. 2016; 3: 3–10 (in Russian).
5. Gushchin I.S. IgE-oposredovannaja giperchuvstvitel’nost’ kak otvet na narushenie bar’ernoj funkcii tkanej [IgE-mediated hypersensitivity as a response to barrier tissue disfunction] // Immunologiya – Immunology. 2015; 36 (1): 45–50 (in Russian).
6. Gushchin I.S. Allergicheskaja pronicaemost’ bar’ernyh tkanej - strategicheskaja problema allergologii [Allergic permeability barrier of tissue is a strategic problem of Allergy] // Pul’monologija – Pulmonology. 2006; 3: 5–13 (in Russian).
7. Gushchin I.S. Jepidermal’nyj bar’er i allergija [Epidermal barrier and allergy] // Rossijskij allergologicheskij zhurnal – Russian Allergology Journal. 2007; 2: 3–16 (in Russian).
8. Gushchin I.S. Preodolenie allergenami tkanevogo bar’era – reshajushhaja forma predraspolozhenija k allergii [Overcoming allergens tissue barrier is the decisive form of predisposition to allergics] // Patologicheskaja fiziologija i jeksperimental’naja terapija – Journal of Pathophysiology and Experimental Therapy. 2009; 9: 8–13 (in Russian).
9. Zhang N., Crombruggen K. Van, Gevaert E., Bachert C. Barrier function of the nasal mucosa in health and type-2 biased airway diseases // Allergy. 2016; 71 (3): 295–304. doi: 10.1111/all.12809.
10. Fedosenko S.V., Ogorodova L.M., Karnaushkina M.A., Kulikov E.S., Deev I.A., Kirillova N.A. The Sostav soobshhestva mikroorganizmov v dyhatel’nyh putjah u zdorovyh lic i bol’nyh bronhial’noj astmoj [Airways Microbial Community Composition in Healthy Individuals and Bronchial Asthma Patients] // Vestnik rossijskoj akademii medicinskih nauk – Annals of the Russian Academy of Medical Sciences. 2014; 3–4: 71–76 (in Russian).
11. Sehti S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive Pulmonary Disease // N. Engl. J. Med. 2008; 359: 2355–2365. doi: 10.1056/nejmra0800353.
12. Rjazanceva S.V., Hmel’nickaja N.M., Tyrnova E.V. Rol’ slizistoj obolochki v zashhite LOR-organov ot potencial’no patogennyh dlja organizma antigennyh faktorov [The role of mucosa in protection of respiratory tract from potentially pathogenic for the organism of antigenic factors] // Vestnik otorinolaringologii – Bulletin of Otorhinolaryngology. 2000; 3: 60–64 (in Russian).
13. Brandtzaeg P. Immunocompetent cells of the upper airway: functions in normal and diseased mucosa // Eur. Arch. Otorhinolaryng. 1995; 252 (1): 8–21. doi: 10.1007/ bf02484429.
14. Brandtzaeg P., Jahnsen F.L., Farstad I.N. et al. Immunobiology and immunopathology of the upper airway mucosa // Folia Otorhinolaryng et Pathol Respiratoriae. 1998; 4 (1–2): 74–83.
15. Beljakov I.M. Immunnaja sistema slizistyh [The immune system of the mucous] // Immunologija – Immunology. 1997; 4: 7–13 (in Russian).
16. Brandtzaeg P. Two types of IgA immunocytes in man // Nature New Biology. 1973; 243 (126): 142–143. doi: 10.1038/newbio243142a0.
17. Pipkorn U., Karlsson G., Enerback L. The cellular response of the human allergic mucosa to allergen exposure // J. Allergy Clin. Immunol. 1988; 82 (6): 172–178. doi: 10.1016/0091-6749(88)90143-1.
18. Bezrukova E.V., Molotilov B.A. Dinamika klinicheskoj kartiny i pokazatelej lokal’nogo immuniteta pri provedenii allergen-specificheskoj immunoterapii pri sochetannyh formah sensibilizacii u bol’nyh pollinozom [Dynamics of clinical symptoms and immunity local parametres during allergen - specific immunotherapy in patents with pollinosis and combined forms of sensibilization] // Rossijskij allergologicheskij zhurnal – Russian Allergology Journal. 2010; 3: 14–18 (in Russian).
19. Shabashova N.V. Mikrobiocenoz i vnutrijepitelial’naja immunnaja sistema zheludochno-kishechnogo trakta cheloveka [Microbiocenosis and intraepithelial immune system of human gastrointestinal tract] // Vestnik Severo-Zapadnogo Medicinskogo Universiteta im. I.I. Mechnikova – Herald of North-Western State Medical University named after I.I. Mechnicov. 2011; 2: 166–178 (in Russian).
20. Manuilov A.M., Bolokov M.S., Gurmikov B.N. Rol’ bar’ernoj funkcii zheludochno-kishechnogo trakta v klinicheskoj praktike. Obzor literatury [The role of barrier function of gastrointestinal tract in clinical practice. Literature review] // Novye tehnologii – New Technologies. 2012; 4: 302–307 (in Russian).
21. Muir A.B., Benitez A.J., Dods K., Spergel J.M., Fillon S.A. Fillon Microbiome and its impact on gastrointestinal atopy // Allergy. 2016, 71 (9): 1256–1263.
22. Vykhristsenko L.R. Metody mukozal’noj specificheskoj allergovakcinacii [Methods of mucosal specific allergovaccination in atopic diseases treatment] // Immunopatologija, allergologija, infektologija – Immunopathology, Аllergology, Infectology. 2001; 4: 63–86 (in Russian).
23. Mowat A.M. Anatomical basis of tolerance and immunity to intestinal antigens // Nat. Rev. Immunol. 2003; 4 (3): 331–341. doi: 10.1038/nri1057.
24. Sheridan B.S., Lefrancois L. Intra-epithelial lymphocytes: to serve and protect // Curr. Gastroenterol. Rept. 2010; 12 (6): 513–521. doi: 10.1007/s11894-010-0148-6.
25. Pavlova K.S. Uhod za kozhej kak sposob vosstanovlenija mikrobioma u bol’nyh atopicheskim dermatitom [Skin care as a way to recover microbiome in patients with atopic dermatitis] // Rossijskij allergologicheskij zhurnal – Russian Allergology Journal. 2014; 1: 17–22 (in Russian).
26. Rabinovich O.F., Rabinovich I.M., Ostrovsky A.D., Abramova E.S., Budikhina A.S., Arshinova S.S. Ocenka mukozal’nogo immuniteta u pacientov s disbakteriozom slizistoj obolochki rta do i posle primenenija kompleksnogo lechenija [Assessment of mucosal immunity in patients with dysbiosis mucous membranes of the mouth prior to and after the application of complex treatment] // Immunologija – Immunology. 2013; 34 (2): 91–94 (in Russian).
27. Hibino K., Samaranayake L.P., Hägg U., Wong R.W., Lee W. The role of salivary factors in persistent oral carriage of Candida in humans // Arch.Oral. Biol. 2009; 54 (7): 678–683. doi: 10.1016/j.archoralbio.2009.04.003
28. Tanida T., Okamoto T., Okamoto A., Wang H., Hamada T., Ueta E., Osaki T. Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis // Oral Pathol. Med. 2003; 32 (10): 586–594. doi: 10.1034/j.1600-0714.2003.00015.x
29. Epishev V.A. Sostojanie polosti rta pri hronicheskih gastritah [Condition of the o.ral cavity in chronic gastritis]. Tashkent: Med. UzSSR, 1972: 162 (in Russian).
30. Ilyina E.A., Khazanov V., Savkin G.D. Sostojanie tolstogo kishechnika u bol’nyh s hronicheskimi formami stomatitov [Status of large intestine of patients with thrush infection] // Stomatologija – Stomatologiya. 1973; 1: 11–13 (in Russian).
31. Panchenko G.V. Sochetannye porazhenija slizistoj obolochki polosti rta i vnutrennih organov [Concomitant lesions of the mucous membrane of the mouth and internal organs]. M.: Medicine Publ., 1979: 190 (in Russian).
32. Diseases of the digestive system / under the editorship. Mavica C.G., Ryssa. M.: Medicine Publ., 1975: 688 (in Russian).
33. Moreillon P., Que Y.-A., Glauser M.P. Staphylococcus aureus (Including Staphylococcal Toxic Shock). In: Principles and practice of infectious disease; G.L. Mandell, Bennett J.E., Dolin R (Eds); 6th ed. Churchill Livingstone, Philadelphia, PA 2005: 2701.
34. Lora V., Hooper Dan R. Littman and Andrew J. Macpherson, Interactions between the microbiota and the immune system // Science. 2012; 336: 1268–1273. doi: 10.1126/science.1223490.
35. Kurbacheva O.M. Allergen-specificheskaja immunoterapija [Allergen-specific immunotherapy] // Rossijskij allergologicheskij zhurnal – Russian Allergology Journal. 2004; 2: 32–38 (in Russian).
36. Kurbacheva O.M., Pavlova K.S. Allergen-specificheskaja immunoterapija [Allergen-specific immunotherapy] // Doktor. Ru – Doctor.Ru. 2010; 53 (2): 16–19.
37. Philippe J. Bousquet, Linda S. Cox, Stephen R. Durham et. al. Subligval’naja immunoterapija Memorandum Vsemirnoj organizacii po allergii 2009 [the Memorandum of the World Allergy Organization 2009] // Astma – Asthma. 2010; 11 (1): 5–57.
38. Novak N., Allam J.-P. Mucosal dendritis cells in allergy and immunotherapy // Allergy. 2011; 66 (s95): 22–24. doi: 10.1111/j.1398-9995.2011.02626.x.
39. Allam J.-P., Stojanovski G., Friedrichs N., Peng W., Bieber T., Wenzel J., Novak N. Distribution of Langerhans cells and mast cells within the human oral mucosa: new applications sites of allergens in sublingual immunotherapy? // Allergy. 2008; 63 (6): 720–727. doi: 10.1111/j.1398- 9995.2007.01611.x.
40. Kurbacheva O.M., Pavlova K.S., Shul’zhenko A. E. Bezopasnost’ allergen-specificheskoj immunoterapii [Safety of allergen-specific immunotherapy] // Pul’monologija – Pulmonology. 2006; 2: 38–43 (in Russian).
41. Kurbacheva O.M., Pavlova K.S., Kozulina I.E. Allergen-specificheskaja immunoterapija: istorija, metody i novye vozmozhnosti [Allergen-specific immunotherapy: history, methods and new opportunities] // Medicinskij sovet – Medical Council. 2013; 3: 10–19 (in Russian).
42. Kurbacheva O.M., Pavlova K.S. Allergen-specificheskaja immunoterapija: sovremennye vozmozhnosti [Allergen-specific immunotherapy: modern opportunities] // Astma i allergija – Asthma and Аllergy. 2015; 3: 16–20 (in Russian).
43. Passalacqua G., Baena-Cagnani C.E., Bousquet J., Canonica G.W., Casale T.B. et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: Speaking the same language // J. Allergy Clin. Immunol. 2013; 132 (1): 93–98. doi: 10.1016/j.jaci.2013.03.039.
44. Novak N., Bieber T., Allam J.-P. Immunological mechanisms of sublingual allergen-specific immunotherapy // Allergy. 2011; 66 (6): 733–739. doi:10.1111/j.1398- 9995.2010.02535.x.
Review
For citations:
Kurbacheva O.M., Amanturlieva M.E. The role of barrier function of mucous membranes in allergic diseases and sublingual allergen-specific immunotherapy. Bulletin of Siberian Medicine. 2017;16(2):32-46. (In Russ.) https://doi.org/10.20538/1682-0363-2017-2-32-46
Views:
1128
Email this article 